Impact of molecular weight on the formation of electrosprayed chitosan microcapsules as delivery vehicles for bioactive compounds.
The molecular weight of chitosan is one of its most determinant characteristics, which affects its processability and its performance as a biomaterial. However, information about the effect of this parameter on the formation of electrosprayed chitosan microcapsules is scarce. In this work, the impact of chitosan molecular weight on its electrosprayability was studied and correlated with its effect on the viscosity, surface tension and electrical conductivity of solutions. A Discriminant Function Analysis revealed that the morphology of the electrosprayed chitosan materials could be correctly predicted using these three parameters for almost 85% of the samples. The suitability of using electrosprayed chitosan capsules as carriers for bioactive agents was also assessed by loading them with a model active compound, (-)-epigallocatechin gallate (EGCG). This encapsulation, with an estimated efficiency of around 80% in terms of preserved antioxidant activity, showed the potential to prolong the antiviral activity of EGCG against murine norovirus via gradual bioactive release combined with its protection against degradation in simulated physiological conditions.
Food Quality and Preservation Department, IATA-CSIC, Avda. Agustin Escardino 7, 46980 Paterna, Valencia, Spain. Electronic address: lggm@iata.csic.es.
Laura G
LG
Gómez-Mascaraque
Department of Microbiology and Ecology, University of Valencia, Valencia, Spain; Molecular Taxonomy Group, IATA-CSIC, Avda. Agustin Escardino 7, 46980 Paterna, Valencia, Spain. Electronic address: gloriasanchez@iata.csic.es.
Gloria
G
Sanchez
Food Quality and Preservation Department, IATA-CSIC, Avda. Agustin Escardino 7, 46980 Paterna, Valencia, Spain. Electronic address: amparo.lopez@iata.csic.es.
Amparo
A
López-Rubio
D000975:Antioxidants / Q000737:chemistry* / Q000494:pharmacology; D000998:Antiviral Agents / Q000737:chemistry* / Q000494:pharmacology; D002214:Capsules; D002392:Catechin / Q000031:analogs & derivatives / Q000737:chemistry; D048271:Chitosan / Q000737:chemistry* / Q000494:pharmacology; D004337:Drug Carriers / Q000737:chemistry* / Q000494:pharmacology; D004560:Electricity; D008970:Molecular Weight; D012212:Rheology
D000975:Antioxidants; D000998:Antiviral Agents; D002214:Capsules; D004337:Drug Carriers; D002392:Catechin; D048271:Chitosan; C045651:epigallocatechin gallate
Antiviral; Catechin; Chitosan; Electrospray; Microencapsulation; Molecular weight